Press release
Biodefense Market worth $38.73 billion by 2030, growing at a CAGR of 11.18% - Exclusive Report by 360iResearch
Biodefense Market | 360iResearch
The Global Biodefense Market to grow from USD 16.58 billion in 2022 to USD 38.73 billion by 2030, at a CAGR of 11.18%.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/biodefense?utm_source=openpr&utm_medium=referral&utm_campaign=sample
FPNV Positioning Matrix:
The FPNV Positioning Matrix is essential for assessing the Biodefense Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).
Market Share Analysis:
The Market Share Analysis offers an insightful look at the current state of vendors in the Biodefense Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
Key Company Profiles:
The report delves into recent significant developments in the Biodefense Market, highlighting leading vendors and their innovative profiles. These include Alnylam Pharmaceuticals, Inc., Altimmune, Inc., Bavarian Nordic A/S, BDO USA, LLP, Bharat Biotech Ltd., Dynport Vaccine Company by General Dynamics Information Technology, Elusys Therapeutics, Inc. by Heat Biologics Inc., Emergent BioSolutions Inc., Evogen, Inc., Ichor Medical Systems, Inc., Pizer Inc., Serum Institute of India Pvt. Ltd., SIGA Technologies, Soligenix, Inc., and Xoma Corporation.
Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/biodefense?utm_source=openpr&utm_medium=referral&utm_campaign=inquire
Market Segmentation & Coverage:
This research report categorizes the Biodefense Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Product, market is studied across Anthrax, Botulism, Radiation, and Small Pox. The Small Pox is projected to witness significant market share during forecast period.
Based on End-User, market is studied across Ambulatory Care Centers, Hospitals, Military, and Research Organizations. The Ambulatory Care Centers is projected to witness significant market share during forecast period.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Biodefense Market, by Product
7. Biodefense Market, by End-User
8. Americas Biodefense Market
9. Asia-Pacific Biodefense Market
10. Europe, Middle East & Africa Biodefense Market
11. Competitive Landscape
12. Competitive Portfolio
13. Appendix
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Biodefense Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Biodefense Market?
3. What is the competitive strategic window for opportunities in the Biodefense Market?
4. What are the technology trends and regulatory frameworks in the Biodefense Market?
5. What is the market share of the leading vendors in the Biodefense Market?
6. What modes and strategic moves are considered suitable for entering the Biodefense Market?
Read More @ https://www.360iresearch.com/library/intelligence/biodefense?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biodefense Market worth $38.73 billion by 2030, growing at a CAGR of 11.18% - Exclusive Report by 360iResearch here
News-ID: 3276043 • Views: …
More Releases from 360iResearch
Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand…
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives
In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the…
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service
In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also…
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone
In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital…
More Releases for Biodefense
Impact Of Emerging Infectious Diseases Enhanced Biodefense Market: Strengthening …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Biodefense Market Through 2025?
In recent times, there has been significant growth in the biodefense market size. The expansion from $18.55 billion in 2024 to $20.29 billion in 2025, at a compound annual growth rate (CAGR) of 9.4%, can be seen. This…
Impact Of Emerging Infectious Diseases Enhanced Biodefense Market: A Significant …
The Biodefense Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Biodefense Market Size and Projected Growth Rate?
The biodefense market has experienced strong growth in recent years. It will grow from $18.55 billion in 2024 to $20.29 billion in 2025, at a compound…
Biodefense Market Growth Forecast till 2032
According to Ameco Research 'Biodefense Market report, the analysts took this into account when estimating the Biodefense Market size and CAGR for the respective industry. The report's author has thoroughly examined the market and concluded that the Biodefense Market 's growth will level off in the coming years. In addition to that, the prominent qualitative information added in the report includes Biodefense Market trends, segmentation, key companies, SWOT, PORTER and…
Biodefense Market 2032
The Biodefense Market focuses on developing, integrating, and applying medical interventions such as drugs and vaccinations to protect against bioterrorism. With increasing global awareness of biological threats, advancements in biotechnological research, and the development of effective countermeasures, this market is experiencing significant growth.
Download Sample Report Copy Of This Report From Here: https://www.amecoresearch.com/sample/276690
Key Points and Statistics:
• Market Size: Projected to reach USD 22,881 Million by 2030, with a CAGR of 5.8%…
Biodefense Market - Enhancing Preparedness, Mitigating Threats: Innovative Biode …
Newark, New Castle, USA - new report, titled Biodefense Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Biodefense market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Biodefense market. The report offers an overview of the market, which briefly describes the…
Biodefense Treatment Market 2025| Target U.S For Maximum Profitability in Biodef …
Even though the UN has a convention against biological warfare, the threat of bioterrorism is greater than ever. To counter rogue pathogens and non-state actors, countries must beef up their R&D budgets of biodefense treatments. COVID-19 has raised numerous questions about global safety and security. Fairfield Market Research estimates that the biodefense treatment market should grow at an exponential rate for the forecast period ending in 2025.
Get Sample of this…
